Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00174980 · ClinicalTrials.gov registry record · Phase 2
Study of Oxycyte in Severe Closed Head Injury
A Phase 2 study, sponsored by Tenax Therapeutics.
- Terminated
- Registry status
- Phase 2
- Development phase
- 9
- Enrollment target
NCT00174980: Clinical Trial Phase 2 study, sponsored by Tenax Therapeutics.
NCT00174980 is a Phase 2 study that was terminated before completion, run by Tenax Therapeutics. The registered enrollment target is 9 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00174980, a Phase 2 study, was terminated before completion, sponsored by Tenax Therapeutics.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 9 participants
- Enrollment target
Study Summary
Brain damage as a result of decreased oxygen to the brain is found in 80% of patients that die with severe head injuries. Laboratory studies in animals and clinical trials have shown that increasing oxygen in the brain results in better brain oxygen consumption, less cell death, and better functional outcome. This study will test the hypothesis that Oxycyte is an effective way to increase brain oxygen levels in severe head injury.
Interventions
- DRUG Oxycyte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2005-09 |
| Est. Completion | 2008-04 |
| Phase | Phase 2 |
Why NCT00174980 stopped before completion
NCT00174980 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Oxycyte is the first listed.
NCT00174980 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00174980 about?
NCT00174980 is a clinical study titled "Study of Oxycyte in Severe Closed Head Injury". Brain damage as a result of decreased oxygen to the brain is found in 80% of patients that die with severe head injuries. Laboratory studies in animals and clinical trials have shown that increasing oxygen in the brain results in better brain oxygen consumption, less cell death, and better functiona...
What is the current status of trial NCT00174980?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2005-09. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00174980?
The interventions under investigation include: Oxycyte (DRUG).
Who is sponsoring clinical trial NCT00174980?
This trial is sponsored by Tenax Therapeutics, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00174980's enrollment target sits among peer trials
9 1989th of 2000 higher than 11 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia